CD19 and diffuse large B-cell lymphoma: Consistently, both Cd19-Cre driven and Cγ1-Cre-driven expression of a Myd88L252P allele, corresponding to the most common activating mutation (L265P) in humans, promotes the occurrence of tumors that share several traits with the human ABC-DLBCL (164).